Antireflux mucosectomy, mucosal ablation compared for gastroesophageal reflux disease

by Elana GotkineFor patients with gastroesophageal reflux disease (GERD), improvement in symptoms is seen with both antireflux mucosectomy (ARMS) and antireflux mucosal ablation (ARMA), but subjective

Updated on: August 08,2024

Antireflux mucosectomy, mucosal ablation compared for gastroesophageal reflux disease

by Elana GotkineFor patients with gastroesophageal reflux disease (GERD), improvement in symptoms is seen with both antireflux mucosectomy (ARMS) and antireflux mucosal ablation (ARMA), but subjective

Updated on:August 08,2024

Study identifies a new disease-inducing mechanism for inflammatory bowel disease

byNewcastle UniversityMicrograph showing inflammation of the large bowel in a case of inflammatory bowel disease. Colonic biopsy. Credit: Wikipedia/CC BY-SA 3.0Interleukin-10 (IL-10) is an anti-

Updated on: August 08,2024

Study identifies a new disease-inducing mechanism for inflammatory bowel disease

byNewcastle UniversityMicrograph showing inflammation of the large bowel in a case of inflammatory bowel disease. Colonic biopsy. Credit: Wikipedia/CC BY-SA 3.0Interleukin-10 (IL-10) is an anti-

Updated on:August 08,2024

Roles of Blimp-1 and c-Maf Unveiled in Inflammatory Bowel Disease Research

Updated on: August 03,2024

Roles of Blimp-1 and c-Maf Unveiled in Inflammatory Bowel Disease Research

Updated on:August 03,2024

A Special Base Editor: Modifying Gut Bacteria Genes

Credit:www.freepik.com“We have always dreamed of achieving this.” — Xavier Duportet, co-founder of the French biotechnology company Eligo Bioscience and synthetic biologistOn July 10, 2024, a technica

Updated on: July 20,2024

A Special Base Editor: Modifying Gut Bacteria Genes

Credit:www.freepik.com“We have always dreamed of achieving this.” — Xavier Duportet, co-founder of the French biotechnology company Eligo Bioscience and synthetic biologistOn July 10, 2024, a technica

Updated on:July 20,2024

'We have treatments': Doctors urge patients with chronic vomiting to not suffer in silence

byAmerican Gastroenterological AssociationCredit: CC0 Public DomainThe American Gastroenterological Association (AGA) has released new clinical guidance to help clinicians and patients recognize

Updated on: July 19,2024

'We have treatments': Doctors urge patients with chronic vomiting to not suffer in silence

byAmerican Gastroenterological AssociationCredit: CC0 Public DomainThe American Gastroenterological Association (AGA) has released new clinical guidance to help clinicians and patients recognize

Updated on:July 19,2024

Subcutaneous therapy improves inflammatory bowel disease treatment, clinical trial finds

by Melissa Rohman,Northwestern UniversityLinear scale mean (SD) serum infliximab concentrations up to week 54 (PK population) in the CD (A) and UC (B) studies. Concentrations below the lower lim

Updated on: July 19,2024

Subcutaneous therapy improves inflammatory bowel disease treatment, clinical trial finds

by Melissa Rohman,Northwestern UniversityLinear scale mean (SD) serum infliximab concentrations up to week 54 (PK population) in the CD (A) and UC (B) studies. Concentrations below the lower lim

Updated on:July 19,2024

Irritable bowel syndrome following gastroenteritis may last 4+ years in around half of those affected

byBritish Medical JournalCredit: Pixabay/CC0 Public DomainIrritable bowel syndrome (IBS)—characterized by abdominal pain, bloating, and altered bowel habit—may last 4 or more years following a b

Updated on: July 17,2024

Irritable bowel syndrome following gastroenteritis may last 4+ years in around half of those affected

byBritish Medical JournalCredit: Pixabay/CC0 Public DomainIrritable bowel syndrome (IBS)—characterized by abdominal pain, bloating, and altered bowel habit—may last 4 or more years following a b

Updated on:July 17,2024

Belonging while battling bowel disease

by Sonya Goins, Mayo Clinic News NetworkHigh magnification micrograph of Crohn's disease. Biopsy of esophagus. H&E stain. Credit: Nephron/WikipediaDealing with chronic conditions like Crohn&#3

Updated on: July 17,2024

Belonging while battling bowel disease

by Sonya Goins, Mayo Clinic News NetworkHigh magnification micrograph of Crohn's disease. Biopsy of esophagus. H&E stain. Credit: Nephron/WikipediaDealing with chronic conditions like Crohn&#3

Updated on:July 17,2024

Regorafenib synergizes with TAS102 against multiple gastrointestinal cancers: Study

by Impact Journals LLCTAS102 in combination with regorafenib inhibits ERK1/2 and STAT3 signaling. Credit: 2024 Zhang et al.A new research paper waspublishedinOncotargettitled,

Updated on: July 10,2024

Regorafenib synergizes with TAS102 against multiple gastrointestinal cancers: Study

by Impact Journals LLCTAS102 in combination with regorafenib inhibits ERK1/2 and STAT3 signaling. Credit: 2024 Zhang et al.A new research paper waspublishedinOncotargettitled,

Updated on:July 10,2024

The Soda Tax Dilemma: Why Sweetened Beverage Taxes Aren't Curbing Obesity

Updated on: July 10,2024

The Soda Tax Dilemma: Why Sweetened Beverage Taxes Aren't Curbing Obesity

Updated on:July 10,2024

New findings may fix the replicability crisis in microbiome research

by Judith Myers,University of California - San DiegoCredit: Pixabay/CC0 Public DomainOur bodies are inhabited by trillions of microorganisms, with specific microbes unique to each individual. Th

Updated on: July 08,2024

New findings may fix the replicability crisis in microbiome research

by Judith Myers,University of California - San DiegoCredit: Pixabay/CC0 Public DomainOur bodies are inhabited by trillions of microorganisms, with specific microbes unique to each individual. Th

Updated on:July 08,2024

Crohn's discovery could lead to better treatments for devastating condition

byUniversity of VirginiaDecreased epithelial detachment in biopsy samples of patients with Crohn's disease compared with controls (**p = 0.006). Credit:Scientific Reports(2024).

Updated on: July 08,2024

Crohn's discovery could lead to better treatments for devastating condition

byUniversity of VirginiaDecreased epithelial detachment in biopsy samples of patients with Crohn's disease compared with controls (**p = 0.006). Credit:Scientific Reports(2024).

Updated on:July 08,2024